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Abstract
The renal collecting duct adapts to changes in acid-base metabolism by remodelling and altering the relative number of
acid or alkali secreting cells, a phenomenon termed plasticity. Acid secretory A intercalated cells (A-IC) express apical
H
+-ATPases and basolateral bicarbonate exchanger AE1 whereas bicarbonate secretory B intercalated cells (B-IC) express
basolateral (and apical) H
+-ATPases and the apical bicarbonate exchanger pendrin. Intercalated cells were thought to be
terminally differentiated and unable to proliferate. However, a recent report in mouse kidney suggested that intercalated
cells may proliferate and that this process is in part dependent on GDF-15. Here we extend these observations to rat kidney
and provide a detailed analysis of regional differences and demonstrate that differentiated A-IC proliferate massively during
adaptation to systemic acidosis. We used markers of proliferation (PCNA, Ki67, BrdU incorporation) and cell-specific markers
for A-IC (AE1) and B-IC (pendrin). Induction of remodelling in rats with metabolic acidosis (with NH4Cl for 12 hrs, 4 and 7
days) or treatment with acetazolamide for 10 days resulted in a larger fraction of AE1 positive cells in the cortical collecting
duct. A large number of AE1 expressing A-IC was labelled with proliferative markers in the cortical and outer medullary
collecting duct whereas no labeling was found in B-IC. In addition, chronic acidosis also increased the rate of proliferation of
principal collecting duct cells. The fact that both NH4Cl as well as acetazolamide stimulated proliferation suggests that
systemic but not urinary pH triggers this response. Thus, during chronic acidosis proliferation of AE1 containing acid-
secretory cells occurs and may contribute to the remodelling of the collecting duct or replace A-IC due to a shortened life
span under these conditions.
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Introduction
The collecting duct is the major site of urinary acidification [1],
a process that involves at least two subtypes of intercalated cells.
Type A intercalated cells (A-IC) secrete protons into urine via a
luminal H
+-ATPase and express on the basolateral side the
chloride/bicarbonate exchanger AE1 (Band3) [2,3]. In contrast,
non-type A intercalated cells are characterized by the apical
expression of the chloride/bicarbonate exchanger pendrin [4],
secrete bicarbonate into urine, and express luminal, basolateral or
bipolar H
+-ATPases [3]. Based on the localization of H
+-ATPases
some authors distinguish two subtypes of these intercalated cells,
type B intercalated cells (with basolateral H
+-ATPase) and non-A/
non-B intercalated cells (luminal H
+-ATPase) [5,6].
During changes in systemic acid-base or electrolyte status, the
collecting duct system (the connecting tubule (CNT), cortical
collecting duct (CCD), outer and inner medullary collecting ducts
(OMCD and IMCD) is remodelled and the relative number of the
different subtypes of intercalated cells and segment specific cells
(connecting tubule cells and principal collecting duct cells) as well
as their morphology alter. Enhanced urinary acid excretion is
accompanied by increased relative number of acid-secretory
intercalated cells [7,8]. Acid-loading of mice, rats or rabbits
increases the number of intercalated cells that express luminal
H
+-ATPases and secrete protons [7,8,9,10,11,12,13]. Whether
these cells were all type A intercalated cells remained open. Other
studies, however, used more refined morphological criteria
including electron microscopy or staining for AE1 as specific
marker for type A intercalated cells [11,12].
Intercalated cells were thought to be terminally differentiated
and to lack the ability to further proliferate [14,15,16].
Remodelling of the collecting duct has therefore been thought to
involve the interconversion of mature and fully differentiated type
A and B intercalated cells, a process termed plasticity [14,15]. In
vitro and in vivo experiments provided evidence that hensin, a
component of the extracellular matrix, may be involved and
required for this adaptive process [14,17,18,19].
Several lines of evidence support the novel concept that the
many types of epithelial cells along the nephron retain or regain
their ability to proliferate, both under normal conditions [20] as
well as in response to different stimuli [21,22,23,24,25,26]. Among
these cells, also intercalated cells were noted to stain for markers of
proliferation raising the possibility that regulated proliferation of
intercalated cells may contribute to the adaptive remodelling of the
collecting duct. Indeed proliferation of intercalated cells during
acidosis has been demonstrated in mouse kidney and it was shown
that GDF-15 may play a role in the early phase of this proliferative
response [25]. Here we extended these observations and
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intercalated cells proliferate in response to systemic acidosis,
whereas non-type A intercalated cells do not proliferate under
these conditions. Regional differences along the nephron exist and
functional data suggest that systemic but not urinary pH is relevant
for triggering the proliferative response.
Materials And Methods
Animals
Male Wistar rats (120–150 g) (Janvier, Belgium) were used.
Animals had free access to water and food. Sucrose, NH4Cl, NaCl,
or acetazolamide were added to the drinking water as detailed
below. Rats were treated in 2 series:
Series 1: Group 1: 2% sucrose for 12 hrs, 4 or 7 days (control);
group 2: 0.28 M NH4Cl plus 2% sucrose for 12 hrs, 4 days, or 7
days.
Series 2: Group 1: 2% sucrose for 7 days (control); group 2:
0.28 M NH4Cl plus 2% sucrose for 4 or 7 days; group 3: 0.28 M
NaCl plus 2% sucrose; group 4: 300 mg/l acetazolamide for 10
days. All animals in series 2 received BrdU injections (10 mg/kg
body weight of 10 mg/ml 5-bromo-29-deoxyuridine (BrdU)
(Sigma-Aldrich, St. Louis, MO) dissolved in 0.9% NaCl s.c.) every
12 hrs for the last 4 days before fixation for immunohistochem-
istry. All groups consisted of at least 4 rats per time point and
treatment for immunohistochemistry and 4 rats for harvesting
kidneys for immunoblotting. All animals were kept in metabolic
cages 48 hrs before sacrifice. Food and water intake and urine
output were monitored by collecting urine over 24 hrs periods
under light mineral oil. Before sacrifice, animals were anesthetized
with isoflurane and arterial blood was taken from the tail artery for
blood gas and electrolyte analysis. All experiments were performed
according to Swiss Animal Welfare laws and were approved by the
local veterinary authorities (Kantonales Veterina ¨ramt Zu ¨rich)(Re-
gulation von renalem Transport in der Ratte, protocol no 52/
2004).
Blood and urine analysis
Arterial blood was injected into a blood gas analyzer
(Radiometer Copenhagen, ABL 505, Denmark) and the following
values were determined: pH, HCO3
2, pCO2,K
+,N a
+,C l
2.
Urine pH was measured immediately. Ion chromatography
(Metrohm ion chromatograph, Switzerland) was performed to
obtain K
+,N a
+,C l
2 concentrations in urine samples. Urine
creatinine was analyzed applying the Jaffe ´ method [27,28]. Urine
ammonium concentration was determined according to the
Table 2. PCNA labeled cells.
AE1+ (%)
AE1+ /
PCNA+ (%) PDS+ (%)
PDS+ /
PCN+ (%) AQP2+ (%)
AQP2+
PCNA+ (%) Total cell number
CNT
Control #1 25.460.8 060 6.560.8 060 68.261.6 1.960.3 1849
NH4Cl 12 hrs 25.561.1 060 4.660.4 060 70.060.8 1.960.3 2457
NH4Cl 4d 25.960.8 060 6.560.5 060 67.661.3 2.060.2 1997
Control #2 26.560.4 060 5.561.1 060 68.061.3 2.060.2 1927
NH4Cl 7d 27.160.4 060 5.660.3 060 67.360.6 1.860.1 1924
CCD
Control #1 12.460.6 0601 7 . 3 61.0 060 70.361.3 1.860.7 1114
NH4Cl 12 hrs 13.060.4 0601 7 . 1 60.7 060 70.060.5 2.560.4 1516
NH4Cl 4d 11.460.3 0601 6 . 2 60.8 060 72.460.8 2.160.2 1213
Control #2 12.660.7 0601 7 . 4 60.2 060 70.060.7 2.660.2 1152
NH4Cl 7d 14.660.8* 3.560.9* 11.160.4* 060 74.360.8 0.860.1* 1176
OMCD
Control #1 35.861.3 0600 600 60 64.261.3 1.660.5 566
NH4Cl 12 hrs 37.360.5 3.260.5* 0600 60 62.760.5 2.460.6 811
NH4Cl 4d 37.761.1* 3.861.9* 0600 60 62.361.2* 2.660.7 623
Control #2 35.561.0 0600 600 60 64.161.0 1.960.3 582
NH4Cl 7d 37.961.0 * 2.560.7* 0600 60 62.161.0* 2.460.5 614
Experiments were carried out in two separate series (#1a n d#2) with the respective control groups. Data are given as mean 6 SEM. * marks significant difference
between control and treated group.
doi:10.1371/journal.pone.0025240.t002
Table 1. Arterial blood data group 1 (PCNA).
control 12 hrs 4 days 7 days
NH4Cl NH4Cl NH4Cl
Blood
pH 7.4660.03 7.2960.01* 7.2660.06* 7.3760.05*
pCO2 (mmHg) 38.562.9 38.361.4 31.962.4* 36.862.5
HCO3
2 (mM) 27.060.4 18.060.4* 14.862.3* 21.062.0*
Na
+ (mM) 137.760.7 139.260.2 140.360.9 136.560.4
K
+ (mM) 5.060.3 4.960.1 4.560.1 4.860.3
Cl
2 (mM) 100.760.7 109.860.7* 113.064.1* 106.363.0*
Rats treated with NH4Cl in drinking water for 12 hrs, 4 or 7 days, n=6 animals/
group. Data are given as mean 6 SEM. * marks significant difference between
control and treated group.
doi:10.1371/journal.pone.0025240.t001
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done according to Chan [30].
Immunoblotting
Animals were anaesthetized, perfused with PBS to remove all
blood, and kidneys were rapidly harvested. Cortex and medulla
were separated by hand-dissection under a stereo-microscope.
After homogenization in an ice-cold K-HEPES buffer (200 mM
mannitol/80 mM K-HEPES/41 mM KOH/pH 7.5) with pep-
statin, leupeptin, K-EDTA, and PMSF as protease inhibitors, the
samples were centrifuged at 100,000 x g for 1 h at 4uC, and the
pellet was resuspended in K-HEPES buffer containing protease
inhibitors. After measurement of the total protein concentration
(Bio-Rad, Hercules, CA), 75 mg of crude membrane protein was
solubilized in Laemmli sample buffer, and SDS-PAGE was
performed on a 10% polyacrylamide gel. For immunoblotting,
the proteins were transferred electrophoretically from unstained
gels to polyvinylidene fluoride membranes (Immobilon-P, Milli-
pore, Bedford, MA). After blocking with 5% milk powder for 1 h,
the blots were incubated with the primary antibodies (rabbit anti-
Figure 2. Early proliferation during induction and adaption to metabolic acidosis. Appearance of PCNA positive type A intercalated cells
during acidosis. Kidney sections were stained with antibodies against either the type A intercalated cell specific AE1 protein (green), or the non-type
A intercalated cell specific pendrin protein (red, asterisk), and antibodies against PCNA (red nuclei). (A) In the OMCD, PCNA labelling was seen in
single cells not stained for AE1 under control conditions (arrow). (B) Co-staining of PCNA was seen in a few AE1 positive cells in the OMCD after 12 hrs
NH4Cl-loading (arrow).
doi:10.1371/journal.pone.0025240.g002
Figure 1. Proliferation of segment-specific cells after 7 days of acidosis in the CCD and OMCD. Animals were treated for 7 days with
NH4Cl or were left untreated (controls). (A,B) Labelling of segment specific cells in the CCD with antibodies against calbindin D28K (green) in the CCD
under control conditions and after 7 days of acidosis: PCNA staining (asterisk) was observed in calbindin D28k positive cells under control conditions
and after 7 days of NH4Cl. (C,D) Segment-specific cells in the OMCD were identified by staining of AQP2 (green). Similarly to the CCD, some OMCD
principal cells were positive for PCNA (asterisk) under control and acidotic conditions.
doi:10.1371/journal.pone.0025240.g001
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guinea-pig anti-mouse pendrin 1.10.000 [31], rabbit anti-mouse
AE1 1:3.000 [32], mouse monoclonal anti-actin (42 kD, Sigma, St.
Louis, MO) 1:5000) either for 2 h at room temperature or
overnight at 4uC. After washing off the primary antibody and
subsequent blocking, blots were incubated with the secondary
antibodies coupled to horse radish peroxidase or alkaline
phosphatase, respectively (Promega, Madison, Wisconsin, USA)
for 1 h at room temperature. Antibody binding was detected with
the enhanced chemiluminescence ECL kit (Amersham Pharmacia
Biotech, UK) or the CDP star kit (Roche, Mannheim, Germany)
before detection with Diana III Chemiluminescence detection
system and quantified with the Aida Image Analyzer software
(Raytest, Germany).
Immunohistochemistry
Tissue fixation and preparation. Rats were anesthetized
by an intraperitoneal injection of pentobarbital (100 mg/kg body
weight) and fixed by vascular perfusion [33]. The fixative
contained 3% paraformaldehyde (PFA), 0.01% glutaraldehyde
(GA) and 0.5% picric acid, dissolved in a 3:2 mixture of 0.1 M
cacodylate buffer (pH 7.4, added with sucrose, final osmolality
300 mosmol/l) and 4% hydroxyl ethyl starch (HES; Fresenius
Kabi, Bad Homburg, Germany) in 0.9% NaCl. The kidneys were
fixed for 5 min, and then rinsed by vascular perfusion with 0.1 M
cacodylate buffer for 5 min. The kidneys were removed from the
animal, cut in two-four millimeter thick slices and immediately
frozen in liquid propane cooled down to 2196uC by liquid
nitrogen. Frozen kidney slices were cut into 4 mm thick cryostat
Figure 3. Proliferation of intercalated cells after 4 days of acidosis is observed in the OMCD but not CCD. Kidney sections were stained
with antibodies against either the type A intercalated cell specific AE1 protein (green), or the non-type A intercalated cell specific pendrin protein
(red, asterisk), and antibodies against PCNA (red nuclei). Animals were treated for 4 days with NH4Cl or were left untreated (controls). (A–C)
Colocalization of PCNA and AE1 in some cells in the CCD after 4 or 7 days of NH4Cl treatment: Pendrin positive cells (*) in the CCD did not show PCNA
labelling at any time point. (D–F) In the OMCD PCNA labelling was found under control conditions in AE1 negative cells (D) whereas colocalization
(arrows) with AE1 could be observed after 4 and 7 days of metabolic acidosis (E,F).
doi:10.1371/journal.pone.0025240.g003
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AQP2 positive cells in the CNT, CCD, and OMCD of rats treated for 12 hrs, 4 or 7 days with NH4Cl in the drinking water. (D–F) Percentage of AE1,
pendrin, or AQP2 positive cells that were also stained for PCNA under the different conditions. * marks significant difference compared to control.
doi:10.1371/journal.pone.0025240.g004
Table 3. Arterial blood and urine data group 2 (BrdU).
control NH4Cl NH4Cl NaCl Acetazol
4 days 7 days 7 days 10 days
Body weight at start (g) 127.661.7 128.963.1 126.662.0 134.162.2 134.261.4
Body weight at the end (g) 174.064.3 154.9 63.9 148.864.8 157.965.4 170.262.8
Blood
pH 7.4360.01 7.2960.06* 7.3760.06* 7.4660.01 7.4060.01
pCO2 (mmHg) 38.661.3 29.461.1* 31.162.4* 39.561.1 37.461.2
HCO3
2 (mM) 25.560.5 14.161.9* 18.162.0* 27.761.3 22.860.4*
Na
+ (mM) 136.060.7 135.661.7 136.061.4 143.562.7* 137.360.3
K
+ (mM) 4.860.2 5.360.3 5.260.4 4.060.1* 4.360.1*
Cl
2 (mM) 103.260.4 117.262.3* 111.063.4* 106.862.0* 105.860.8*
Urine
pH 6.8660.08 5.9360.15* 5.9960.13* 6.4160.07 7.2760.03*
Volume (ml/ 24 hrs) 28.863.4 10.06 1.4* 9.561.0* 106.1616.3* 19.461.5*
Creatinine (mg/dl) 15.563.1 25.362.7* 44.068.8* 3.360.4* 15.860.9
NH4
+/ Creatinine (mM/mg/dl) 0.760.1 8.460.7* 8.460.8* 0.860.1 1.360.1*
Na
+/ Creatinine (mM/mg/dl) 1.560.6 1.660.2 2.860.5 133.2622.9* 3.560.3*
K
+/ Creatinine (mM/mg/dl) 2.160.8 4.060.5 4.860.6 4.860.7 7.760.5*
Cl
2/ Creatinine (mM/mg/dl) 2.060.7 11.160.6* 16.260.4* 131.9621.3* 4.860.6
TA mmol/l 4.261.4 63.6611.1* 63.967.3* 20.561.0* 242.163.1*
NAE mmol/l 14.561.9 353.0618.1* 365.2612.6 2.161.1 220.564.7*
NAE/Creatinine
(mM/mg/dl)
0.860.1 10.461.0* 10.161.0* 0.860.4 21.460.3*
Rats treated with NH4Cl for 4 or 7 days, NaCl for 7 days, or acetazolamide for 10 days. Blood was taken under anesthesia from tail arteries, urine was collected over
24 hrs in metabolic cages. N=10 animals/ group, * marks significant difference between control and treated group.
Values are means 6 SEM, TA titratable acids, NAE net acid excretion.
doi:10.1371/journal.pone.0025240.t003
Proliferation of Intercalated Cells
PLoS ONE | www.plosone.org 5 October 2011 | Volume 6 | Issue 10 | e25240sections. Sections were rinsed 3610 min in 50 mM NH4Cl/PBS
in order to wash out glutaraldehyde fixative and to reduce
background staining. In all protocols that included detection of
PCNA or BrdU the cryostat sections were microwaved for 15 min
in 0.01 M citrate buffer at pH 6.0. After pretreatment in 5%
normal goat serum in PBS, the cryostat sections were incubated
overnight in a humidified chamber at 4uC with the primary
antibodies (see below), diluted in PBS-1% BSA. After incubation
with primary antibodies, sections were rinsed three times with PBS
and covered for 1 h at room temperature in the dark with the
appropriate secondary antibodies coupled to FITC or Cy3. After
rinsing with PBS, the sections were finally plated on coverslips with
DAKO-Glycergel (Dakopatts) containing 2.5% 1,4-diazabicyclo
(2.2.2.) octane (DABCO; Sigma, St. Louis, MO, USA) as a fading
retardant, and studied on an epifluorescence microscope (Polyvar,
Reichert-Jung). For nuclear staining, 49,6-diamidino-2-
phenylindole (DAPI; Sigma, St. Louis, MO, USA), diluted
1:200, was added to the secondary antibodies. Double/triple
labellings were performed using cocktails of mouse, rabbit, and
guinea-pig primary antibodies, and of the respective secondary
antibodies. No cross-reactivity between primary and secondary
antibodies was observed by omitting primary antibodies.
All sections from different animal groups within one series were
processed simultaneously with the same dilutions of primary and
secondary antibodies.
Antibodies. The following primary antibodies were used at
the dilutions given: rabbit anti-AE1 1:200 [32], human anti-AQP2
(kindly provided by M. Knepper, USA) 1:50.000, rabbit anti-
calbindin-D28k (SWANT, Bellinzona, Switzerland) 1:50.000,
guinea pig anti-pendrin diluted 1:100.000, mouse monoclonal
anti-bromodeoxyuridine (BrdU) clone 3D4 (BD Biosciences
Pharmingen, San Diego, CA, USA) 1:300, mouse monoclonal
anti-proliferating cell nuclear antigen (PCNA) (Dako Cytomation
clone PC 10) 1:400, and rabbit anti-Ki67 (Novacastra
Laboratories, Newcastle, UK).
TUNEL assay. Apoptotic cells were stained by the use of the
TUNEL (terminal deoxynucleotidyl transferase mediated dUTP
Nick End Labeling) method (Apop-TagH; Chemicon; VWR
International Dietikon, Switzerland), which specifically labels the
39-OH blunted ends of the fragmented DNA. The kit was used as
recommended by the supplier.
Quantification of cells. To count cells, six sections from
each animal for each set of incubations were analyzed. Basolateral
AE1-stained cells were counted as type A intercalated cells, cells
with apical staining for pendrin were counted as non-type A
intercalated cells. Non-stained cells were identified as principal
cells. In a separate set of incubations, AQP2 or calbindin-D28k
were used to confirm principal cells. Single cells were positively
identified by DAPI staining of nuclei. A total of 72 digital images
(12 images for a section) were examined from each experimental
animal with a total of 1200 counted cells/ animal.
Statistics
All data are presented as means 6 SEM. All data were tested for
significance using the unpaired t-Test or one way ANOVA test, and
only results with p,0.05 were considered statistically significant.
Results
Acute proliferation of collecting duct cells
Several protocols have been described that induce metabolic
acidosis and remodelling of the collecting duct in mouse and rats
including treatment with NH4Cl [34,35,36,37]. In a first series of
animals, NH4Cl was given to induce metabolic acidosis which was
confirmed by blood gas analysis. Metabolic acidosis was evident in
all groups given NH4Cl as shown by lower blood pH and
bicarbonate levels (table 1).
Acutely proliferating cells express the PCNA and Ki67 antigens
in their nuclei and can be identified based on immunohistochem-
istry [26,38]. Antibodies against PCNA or Ki67 were combined
with antibodies directed selectively against cell-specific markers of
type A (AE1) [2] and non-type A (pendrin) [4] intercalated cells,
respectively, as well as against segment-specific cells (AQP2 and
calbindin D28k) [39]. We did not observe any colocalization in the
same cell of these cell-specific markers in any segment of the
collecting duct under all conditions tested (data no shown) in
agreement with previous reports [2,5,39,40,41]. PCNA and Ki67
labelling showed identical results (data not shown) and we
Figure 5. Regulated expression of AE1, pendrin, and AQP2 during different treatments. Immunoblotting of total membranes prepared
from cortex and medulla demonstrated regulation of AE1, pendrin and AQP2 in the different treatment groups. N=4 animals/ group.
doi:10.1371/journal.pone.0025240.g005
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analysis. In kidneys from control animals, a small number of cells
in the CNT, CCD, and OMCD stained positive for PCNA and all
these cells were positive for AQP2 or calbindin D28k demon-
strating a low rate of proliferation of segment-specific cells in
normal rat kidney (table 2, figure 1). No colocalization with PCNA
was detected in cell stained for pendrin or AE1 under control
conditions (figures 2 and 3).
Treatment of rats with NH4Cl caused remodelling of the
collecting duct after 7 days as demonstrated by a small but
significant increase in AE1 positive cells in the CCD from
12.660.7% to 14.660.8% and a concomitant reduction in the
relative number of pendrin positive cell from 17.460.2% to
11.160.4 (table 2, figure 4). Also in the OMCD, the relative
abundance of AE1 positive cells increased after 4 and 7 days of
NH4Cl with a parallel reduction in AQP2 positive cells. No
apparent changes in the relative cell numbers for AE1, pendrin or
AQP2 positive cells could be found at any time point in the CNT.
Hence, under the present experimental conditions remodelling in
rat kidney may primarily occur in the CCD and OMCD with an
earlier appearance in the OMCD. Similarly, after 7 days, a subset
of AE1 positive cells in the CCD stained for PCNA, whereas in the
OMCD colocalization of PCNA and AE1 was found as early as
12 hrs after induction of metabolic acidosis indicating that
differentiated type A intercalated cells were undergoing prolifer-
ation (table 2, figures 2 and 4). The number of PCNA positive
Figure 6. Proliferation of segment specific cells in the connecting tubule (CNT). Kidney sections were stained with antibodies against
calbindin D28k (green), a marker of segment-specific cells in the CNT, and against BrdU (red). Colocalization of both stainings was observed in cells of
animal groups in the CNT (arrows).
doi:10.1371/journal.pone.0025240.g006
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groups with one exception. The number of PCNA positive cells
was lower after 7 days of NH4Cl treatment in the OMCD (figure 4,
table 2).
Cumulative rate of proliferation is increased during
metabolic acidosis
PCNA and Ki67 mark only cells that acutely proliferate [26,38].
In order to assess the rate of proliferation over a longer period of
treatment, we used a second group of animals. Rats were injected
every 12 hours with BrdU that is incorporated into the DNA of
proliferating cells. In this second group of animals we also tested if
loading with equimolar amounts of NaCl affected the rate of
proliferation as chloride has been shown to affect the function and
morphology of intercalated cells [31,42,43,44]. We also included
another group of rats, treated with the carbonic anhydrase
inhibitor acetazolamide which induces a mild metabolic acidosis
with alkaline urine and also causes remodelling of the collecting
duct [13]. To further control the effects of the different treatments,
animals were placed in metabolic cages for urine analysis, and
kidneys were used to assess the regulated expression of cell specific
markers (AE1, pendrin, AQP2) separately in cortex and medulla
by immunoblotting.
Acid-loading with NH4Cl induced hyperchloremic metabolic
acidosis (table 3) whereas NaCl-loading did not affect systemic
acid-base status. Acetazolamide induced a very mild and
compensated metabolic acidosis as evident from lower arterial
bicarbonate levels (table 3). NH4Cl treatment stimulated urinary
acidification and increased urinary acid excretion, whereas
acetazolamide caused more alkaline urine and reduced urinary
net acid excretion as expected. Immunoblotting showed increased
abundance of AE1 and AQP2 in cortex and medulla after 4 and 7
days of NH4Cl-loading (Figure 5). Pendrin expression was reduced
under these conditions. NaCl-loading also enhanced AE1 and
AQP2 expression in cortex and medulla, whereas pendrin
expression was decreased (data not shown). Acetazolamide
treatment increased AE1 in cortex but not in medulla, pendrin
expression remained unaltered, and AQP2 abundance slightly
increased in cortex and medulla (Figure 5).
Immunohistochemistry detecting BrdU-labelled cells that had
undergone proliferation in combination with cell-type specific
markers showed no colocalization of BrdU with AE1 or pendrin in
the connecting tubule (CNT) in all groups tested (Figure 6). In
contrast, in the CCD and OMCD, NH4Cl-loading induced a
time-dependent increase in proliferation with many type A
intercalated cells having incorporated BrdU after 7 days
(Figures 7 and 8, table 4). In the OMCD, 10.861.1% of all cells
were positive for AE1 and BrdU, corresponding to about 25% of
all intercalated had incorporated BrdU during 4 days of NH4Cl-
loading. This number increased to 28.160.9% of all cells being
positive for AE1 and BrdU after 7 days of NH4Cl-loading (or
almost 80% of all OMCD intercalated cells)(table 4). Also
Figure 7. Proliferation of type A intercalated cells during
metabolic acidosis. Kidney sections were stained with antibodies
against AE1 (green), pendrin (red, asterisk), and BrdU (red nuclei). (A–E)
Localization of BrdU positive cells in the CCD of control rats (A) or
animals on NaCl for 7 days (B), NH4Cl for 4 or 7 days (C,D), or receiving
acetazolamide for 10 days (E). BrdU colocalized with AE1 in NH4Cl or
acetazolamide treated rats (arrows). (F–K) Colocalization of BrdU and
AE1 staining (arrows) in OMCD intercalated cells in rats treated with
NH4Cl (H, I) or acetazolamide (K) but not in control (F) or NaCl treated
(G).
doi:10.1371/journal.pone.0025240.g007
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PLoS ONE | www.plosone.org 8 October 2011 | Volume 6 | Issue 10 | e25240Figure 8. Remodelling and BrdU positive cell counts. (A) Summary of cells counts assessing the relative abundance of AE1, pendrin or AQP2
positive cells in the CNT, CCD, and OMCD of rats treated for 4 or 7 days with NH4Cl, 7 days with NaCl, or 10 days of acetazolamide in the drinking
water. (B) Percentage of AE1, pendrin, or AQP2 positive cells that were stained for BrdU and the respective cell marker under the different conditions.
* marks significant difference compared to control.
doi:10.1371/journal.pone.0025240.g008
Table 4. BrdU labeled cells.
AE1 pos (%)
AE1 pos +
BrdU pos (%) PDS pos (%)
PDS pos +
BrdU pos (%) AQP2 pos (%)
AQP2 pos
BrdU pos (%)
Total cell
number
CNT
Control 26.260.2 0606 . 3 60.1 060 67.360.3 2.760.2 3262
NaCl 27.160.2 0606 . 6 60.1 060 66.460.1 2.660.3 2570
NH4Cl 4d 25.860.3 0606 . 6 60.2 060 67.560.5 1.960.2 3365
NH4Cl 7d 27.260.3 0605 . 6 60.2 060 67.260.3 2.660.3 2606
Acetazol 28.260.2 0606 . 0 60.2 060 65.860.3 1.960.1 2559
CCD
Control 10.960.4 060 15.160.5 060 74.060.9 2.860.3 2049
NaCl 11.460.2 1.060.7 15.660.3 060 73.060.5 4.160.4 1754
NH4Cl 4d 11.560.3 3.061.2* 16.160.6 060 72.461.0 2.960.2 2157
NH4Cl 7d 16.660.4* 14.561.3* 10.160.2* 060 73.360.4 7.060.5* 2042
Acetazol 16.560.4* 4.361.3* 12.360.2* 060 71.260.4 2.960.4 1757
OMCD
Control 36.260.5 0600 600 60 63.860.5 6.360.9 1065
NaCl 36.360.3 1.260.1* 0600 60 63.760.3 8.161.0 914
NH4Cl 4d 38.060.4 10.861.1* 0600 60 62.060.4 2.660.6* 1077
NH4Cl 7d 41.660.7* 28.160.9* 0600 60 58.460.7 14.160.8* 1288
Acetazol 50.160.4* 17.960.1* 0600 60 49.960.4* 8.060.8 901
Data are given as mean 6 SEM.
*marks significant difference between control and treated group.
doi:10.1371/journal.pone.0025240.t004
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intercalated cells. NaCl loading was without effect on type A
intercalated cells. We did not detect colocalization of pendrin
staining and BrdU labelling under any condition. Thus, chronic
NH4Cl loading or treatment with acetazolamide are associated
with significant rates of proliferation of type A intercalated cells in
CCD and OMCD. We also searched for mitotic figures but
detected only very few that did not allow further statistic analysis
(data not shown).
Few AQP2 or calbindin D28k stained segment-specific cells
were positive for BrdU under control conditions indicating a low
rate of proliferation of CNT, CCD, and OMCD segment-specific
cells under basal conditions as described previously in mouse [21].
Chronic NH4Cl application (7 days) increased BrdU labelling of
CCD and OMCD segment-specific cells (Figures 5, 7, and 9,
table 4). Acetazolamide and NaCl application was without
detectable effect on BrdU incorporation.
Detailed cell counting of type A intercalated cells, non-type
A intercalated cells, and segment-specific cells demonstrated
remodelling in the CCD and OMCD of rats treated with NH4Cl
for 7 days resulting in an increased relative abundance of type A
intercalated cells (figure 6, table 4) similar to the first series of
animals. In addition, acetazolamide treatment also increased the
relative number of type A intercalated cells in the CCD and
OMCD at the expense of non-type A intercalated cells in the CCD
and segment-specific cells in the OMCD, respectively (figure 6,
Figure 9. Proliferation of segment-specific cells in the outer medullary collecting duct (OMCD). Kidney sections were stained with
antibodies against the AQP2 water channel (green), a marker of segment-specific cells, and against BrdU (red). Colocalization of both stainings was
observed in cells of animal groups in the OMCD (arrows).
doi:10.1371/journal.pone.0025240.g009
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using similar treatments [11,13].
Discussion
Remodelling of various nephron segments has been described in
different genetically altered mouse models, disease models, or various
physiological conditions [11,13,19,21,22,23,24,45,46,47,48,49,50].
Remodelling often contributes to the compensation of lossof function
or the adaptive increase in transport capacity to match altered
physiological conditions. Hypertrophy of cells, proliferation of cells,
or removal of cells through apoptosis can often be observed during
remodelling and may contribute to adaptation to various degrees.
During metabolic acidosis, extensive remodelling of the collecting
duct has been described including hypertrophy of intercalated cells
and an increase in the relative cell number of acid-secretory type A
intercalated cells over principal cells [11,12,31,51]. Several observa-
tions may explain remodelling during metabolic acidosis. Intercon-
versionoftypeAandnon-typeAintercalatedcellshasbeendescribed
under in vitro conditions of acute acidosis such as in isolated perfused
rabbit CCD [52] or in cell culture [16,17,53]. A role for hensin, an
extracellular matrix protein, and b1 integrin in this process has been
proposed [14,19]. More recently, mouse models deficient for hensin
or b1 integrin have been described that develop distal renal tubular
acidosis and lack normal type A intercalated cells [18]. Thus, hensin
and b1 integrin may be involved in the normal development of the
collecting duct and differentiation of intercalated cells similarly to the
transcription factors such as Foxi1 and CP2L1 or the signalling
molecules GDF15 or Notch [25,54,55,56]. However, the role of
hensin, b1 integrin, Foxi1, CP2L1 and the Notch pathway in the
adaptive remodelling of the collecting duct to acid-loading has not
been determined in vivo to date. Mice lacking GDF-15 show a
reduced adaptation to acute acid-loading with more pronounced
acidosis and a lower number of intercalated cells proliferating
suggesting that proliferation may contribute to the early phase of
adaptation (e.g. 1–3 days) but not to the chronic phase [25].
Here we describe that cell proliferation of type A intercalated
cells precedes and parallels remodelling in the CCD and OMCD
of acidotic rats. Strikingly, no proliferation and no remodelling
were observed in the CNT. Increased proliferation was observed
as early as 12 hours after induction of acidosis and thereby
preceded the remodelling of the collecting duct. During seven days
Figure 10. No detectable apoptosis of pendrin positive cells during metabolic acidosis. (A–E) Tissue sections were stained for pendrin
(red) and TUNEL labelling (green) was performed to detect apoptotic cells. Under all conditions tested no apoptotic cells could be detected in the
CNT, CCD or OMCD. (F) Apoptotic cells (green) were detected in kidneys from rats treated with the diuretic metolazone inducing apoptosis as
described previously [50]. Cell nuclei were also stained with DAPI (blue).
doi:10.1371/journal.pone.0025240.g010
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CCD and about one third of all intercalated cells in the outer
medullary collecting duct had proliferated as indicated by BrdU
incorporation. However, BrdU detects only cells that had
proliferated but does not allow identifying the precursor cells. In
contrast, the costaining of Ki67 or PCNA with AE1 or pendrin
allowed the detection of fully differentiated intercalated cells
during proliferation. PCNA (proliferating cell nuclear antigen)
participates in DNA synthesis and is therefore detected only
during the S-phase of the cell cycle [57,58]. Ki-67 can be detected
during all active phases of the cell cycle (G1,S ,G 2, and mitosis),
but is not detected in resting cells (G0 phase) [59]. Thus, the
detection of AE1 positive cells expressing also PCNA or Ki-67
identified without doubt these cells as fully differentiated and
proliferating cells.
Under the same conditions we did not find BrdU incorporation
or colocalization of Ki67 or PCNA with pendrin suggesting that
non-type A intercalated cells did not proliferate during acid-
loading consistent with the reduction in the relative abundance of
pendrin positive cells. Wehrli et al, however, has shown BrdU
incorporation in pendrin positive intercalated cells in mouse
kidney suggesting that also these cells may be capable of
proliferation [21]. AQP2 positive cells showed under basal
conditions as well as during the different treatments always BrdU
incorporation and staining for PCNA or Ki67 confirming a
previous report that showed also constant proliferation of segment-
specific cells [21]. Our results do not indicate if acidosis increases
the total number of acid-secretory cells or rather shifts the relative
abundance at the expense of the other cell types. Removal of
pendrin expressing intercalated cells from the medulla during
kidney development by apoptosis has been described [60,61]. We
tested for the occurrence of apoptosis using the TUNEL assay but
could not detect any positive intercalated cells whereas distal
convoluted cells in thiazide treated rats stained positive as reported
previously (figure 10) [50].
The signal for proliferation is most likely systemic acidosis but
not acidic urine since we could observe a similar proliferative
response with NH4Cl-loading and acetazolamide treatment. The
first stimulates urinary acidification whereas the latter is associated
with a more alkaline urine due to bicarbonate losses. Similarly,
Bagnis et al had observed an increased abundance of type A
intercalated in rat kidney after chronic treatment with acetazola-
mide [13]. However, the signal(s) stimulating type A intercalated
cell proliferation and collecting duct remodelling remains to be
determined.
In summary, we demonstrate that fully differentiated type A
intercalated maintain or regain their ability to proliferate during
adaptation to systemic acid-loading. The time course suggests that
this proliferation participates in the remodelling of the collecting
duct or may contribute to the replacement of type A intercalated
cells.
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